← Back
$PTHS All transactions

Pelthos Therapeutics Inc.

M

$ Value

$0

Shares

8,493

Price

$0

Filed

Dec 12

Insider

Name

Pauls Matthew

Title

CIK

0001573429

Roles

Director

Transaction Details

Transaction Date

2025-07-02

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,985

Footnotes

As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units ("RSUs"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years. | On December 10, 2025, the Reporting Person transferred 9,542 shares of Common Stock to GP 2024 Trust, U/A Dated, 12/20/2024, for no consideration. The Reporting Person is not a trustee and does not retain investment or voting control over the shares. Following the gift, the Reporting Person disclaims beneficial ownership of the shares held by the Trust and reports beneficial ownership herein only to the extent of any pecuniary interest, if any. | Each RSU represents a contingent right to receive one share of issuer's Common Stock.

Filing Info

Accession No.

0001753926-25-001884

Form Type

4

Issuer CIK

0001919246

Pauls Matthew's History

Date Ticker Type Value
2026-04-02 PTHS $9K
2026-04-02 PTHS $8K
2025-12-16 SVRA G $0
2025-12-14 SVRA F $1.4M
2025-12-10 SVRA G $0
2025-12-10 PTHS G $0
2025-10-02 PTHS M $0
2025-10-02 PTHS M $0
2025-07-02 PTHS A $0
2025-07-02 PTHS A

Other Insiders at PTHS (90d)

Insider Bought Sold Last
Greenleaf Peter $17K 2026-04-02
Davis Todd C 2025-07-02
Francis Knuettel II
CFO, Treas & Secty
2025-07-02
Pauls Matthew $16K 2026-04-02
Friedberg Ezra M $12K 2026-04-02
Plesha Scott M.
CEO and President
2025-07-02
Malamut Richard $12K 2026-04-02
Baxter Richard B 2025-07-02
Rangarao Sai
Chief Commercial Officer
2025-07-02